Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Feb 26, 2020, before the open
10-K filed Mar 16, 2020, 76 days after period end · 0001171843-20-001755
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $30.97M | $33.86M | $21.65M | $26.42M |
| Net Income | $550.00K | $2.86M | $999.00K | -$1.32M |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| $0.02 |
| $0.08 |
| $0.03 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
